India's Wockhardt, facing a raft of regulatory issues from the U.S. and Europe, is beefing up its quality oversight with a new leader for its regulatory and compliance division. According to The Economic Times, the generic drugmaker has hired Zoher Sihorwala, a 20-year veteran, away from competitor Dr. Reddy's Laboratories, where he was vice president of global regulatory affairs. In December, the FDA issued an import alert against Wockhardt's plant in Chikalthana, India, after earlier banning its facility in Waluj from shipping to the U.S. EU authorities have banned products from three of its facilities. Story | More